Monoclonal antibody raised in mouse against human p300 (E1A Binding Protein P300) by DNA immunization in which the C-terminal part of the protein was cloned and expressed.
EP300
Reaktivität: Human
IHC (p), DB
Wirt: Kaninchen
Polyclonal
RB7876
unconjugated
Applikationshinweise
ChIP/ChIP-seq 5 μg:ChIP
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.9 μg/μL
Buffer
PBS, 0.05 % azide, 0.05 % ProClin300
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Target
p300 (EP300)
(E1A Binding Protein P300 (EP300))
Andere Bezeichnung
p300
Hintergrund
P300 (UniProt/Swiss-Prot entry Q09472) is a histone acetyltransferase that regulates transcription via chromatin remodelling. As such it is important for cell proliferation and differentiation. p300 is able to acetylate all four core histones in nucleosomes. Acetylation of histones is associated with transcriptional activation. p300 also acetylates non-histone proteins such as HDAC1 leading to its inactivation and modulation of transcription. It has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in the p300 gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer.